Filter Results
:
(674)
Show Results For
-
All HBS Web
(674)
- People (1)
- News (189)
- Research (383)
- Events (1)
- Multimedia (15)
- Faculty Publications (240)
Show Results For
-
All HBS Web
(674)
- People (1)
- News (189)
- Research (383)
- Events (1)
- Multimedia (15)
- Faculty Publications (240)
David A. Moss
David Moss is the Paul Whiton Cherington Professor at Harvard Business School, where he teaches in the Business, Government, and the International Economy (BGIE) unit. He earned his B.A. from Cornell University and his Ph.D. from Yale. In 1992-1993, he served as a... View Details
- March 2023
- Teaching Note
VideaHealth: Building the AI Factory
By: Karim R. Lakhani
Teaching Note for HBS Case No. 621-021. The case “VideaHealth: Building the AI Factory” examines the creation of dental startup VideaHealth (Videa) and the development of its artificial intelligence (AI)-led business strategy through the eyes of founder and CEO Florian...
View Details
- 09 Mar 2009
- Research & Ideas
How to Revive Health-Care Innovation
The patient is weak, the situation is serious, but a cure is on the horizon—if we think differently about the underlying problem. Specifically, we need to innovate in health care just the way it is done in any other industry, by tackling...
View Details
- 16 Apr 2019
- First Look
New Research and Ideas, April 16, 2019
including patients, physicians, employers, insurance companies, and the government need to recognize that value is best defined as “a given health outcome per dollar of cost expended.” In this article, we...
View Details
Keywords:
Dina Gerdeman
- April 2017
- Case
China Hospitals Inc.: The Growth of Private Hospitals in China
By: Kevin Schulman, Xiao Yu and Ariel Hwang
This case examines the privatization of hospitals in China. China Hospitals, Inc. has become the largest for-profit hospital company in China, purchasing government owned hospitals in Tier 2 cities. The case profiles CEO Frank Hu. To build his company, he has to...
View Details
- 21 May 2012
- Research & Ideas
OSHA Inspections: Protecting Employees or Killing Jobs?
With an election looming and the economy continuing to struggle, the effectiveness of government regulation has become a political football. While advocates hold regulations up as necessary to protect public health and safety, critics see...
View Details
Keywords:
by Michael Blanding
- November 2020 (Revised April 2021)
- Case
Roll-Ups and Surprise Billing: Collisions at the Intersection of Private Equity and Patient Care
By: Trevor Fetter and Kira Seiger
This case describes the increasing investment by private equity (PE) firms in patient care and other healthcare services. The case focuses on investments in physician staffing firms and roll-up strategy investments in physician practice management (PPM). Included in...
View Details
Keywords:
Business Ventures;
Acquisition;
Mergers and Acquisitions;
Business Model;
Change;
Disruption;
Fluctuation;
Trends;
Customers;
Customer Value and Value Chain;
Ethics;
Fairness;
Finance;
Equity;
Insurance;
Private Equity;
Geography;
Geographic Scope;
Health;
Health Care and Treatment;
Markets;
Demand and Consumers;
Supply and Industry;
Industry Structures;
Ownership;
Ownership Type;
Private Ownership;
Relationships;
Agency Theory;
Business and Community Relations;
Business and Shareholder Relations;
Business and Stakeholder Relations;
Networks;
Strategy;
Competition;
Consolidation;
Expansion;
Integration;
Horizontal Integration;
Vertical Integration;
Value;
Value Creation;
Health Industry;
Health Industry;
United States
Fetter, Trevor, and Kira Seiger. "Roll-Ups and Surprise Billing: Collisions at the Intersection of Private Equity and Patient Care." Harvard Business School Case 321-049, November 2020. (Revised April 2021.)
- September 2011
- Supplement
Narayana Hrudayalaya Heart Hospital
By: Tarun Khanna and Tanya Bijlani
Narayana Hrudayalaya (NH) is one of the world's busiest heart hospitals, where surgeons perform 30-35 complex cardiac surgeries daily. With an average cost of $1,800 per surgery, the hospital treats patients at affordable prices, and does not turn away even the poorest...
View Details
Keywords:
Buildings and Facilities;
Experience and Expertise;
Cost Management;
Insurance;
Health Care and Treatment;
Resource Allocation;
Time Management;
Emerging Markets;
Infrastructure;
Cooperative Ownership;
Quality;
Social Enterprise;
Health Industry;
Karnataka
Khanna, Tarun, and Tanya Bijlani. "Narayana Hrudayalaya Heart Hospital." Harvard Business School Multimedia/Video Supplement 712-802, September 2011.
- April 1995 (Revised August 1995)
- Case
Empire Blue Cross and Blue Shield (A)
By: Regina E. Herzlinger and Ramona Hilgenkamp
Mounting financial losses and increasing public scrutiny present many challenges to the board of directors of a large nonprofit health insurer. This case series presents chronologically the increasing problems of the company.
View Details
Keywords:
Governing and Advisory Boards;
Corporate Governance;
Financial Condition;
Organizational Culture;
Problems and Challenges;
Nonprofit Organizations;
Insurance Industry
Herzlinger, Regina E., and Ramona Hilgenkamp. "Empire Blue Cross and Blue Shield (A)." Harvard Business School Case 195-216, April 1995. (Revised August 1995.)
- 02 Aug 2021
- Blog Post
Uncovering the Virtual Advantage at Humana
previous two months began receiving phone calls about internship cancellations. Difficult choices were made all around as organizations and students scrambled to pivot in a landscape that remained uncertain. Yet, for Humana, a Fortune 500 View Details
- 27 Sep 2011
- First Look
First Look: September 27
healthcare spending in 2015 and 2020, especially for expenditures on prescription drugs in nominal terms and as a percentage of overall health spending. The article concludes with a discussion of the political economy of View Details
Keywords:
Sean Silverthorne
- July 2023
- Case
DayTwo: Going to Market with Gut Microbiome (Abridged)
By: Ayelet Israeli
DayTwo is a young Israeli startup that applies research on the gut microbiome and machine learning algorithms to deliver personalized nutritional recommendations to its users in order to minimize blood sugar spikes after meals. After a first year of trial rollout in...
View Details
Keywords:
Business Startups;
AI and Machine Learning;
Nutrition;
Market Entry and Exit;
Product Marketing;
Distribution Channels
Israeli, Ayelet. "DayTwo: Going to Market with Gut Microbiome (Abridged)." Harvard Business School Case 524-015, July 2023.
- March 2008
- Case
Novartis AG: Science-Based Business
By: H. Kent Bowen and Courtney Purrington
Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in 2007. Pharmaceuticals account for slightly over $24B of that total. In 2007,...
View Details
Keywords:
Innovation and Invention;
Resource Allocation;
Product Development;
Partners and Partnerships;
Research and Development;
Science-Based Business;
Pharmaceutical Industry
Bowen, H. Kent, and Courtney Purrington. "Novartis AG: Science-Based Business." Harvard Business School Case 608-136, March 2008.
- August 2003 (Revised July 2023)
- Case
Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment
By: Regina E. Herzlinger and John McDonough
What can Dr. Dean Ornish learn from the successes and failures of his competitors in ameliorating morbid obesity to create a business model that will “do good” by combatting obesity and associated chronic diseases and “do well” by growing a widely adopted business?...
View Details
Keywords:
Three Pillars;
Industry Analysis;
Health Disorders;
Health Care and Treatment;
Innovation and Invention;
Business Model;
Analysis;
Innovation and Management;
Medical Specialties;
Mission and Purpose;
Health Industry
Herzlinger, Regina E., and John McDonough. "Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment." Harvard Business School Case 304-009, August 2003. (Revised July 2023.)
- 02 Mar 2023
- Blog Post
Women, Work, and the "M" Word
helpful from their employer (62%) and health insurance carriers (73%). Yet, most U.S. workplaces—unlike their British counterparts—do not offer benefits specifically geared towards menopause. This is exactly...
View Details
- January 2023
- Case
Thomas Buberl: Refounding AXA
By: Hubert Joly, Mihir Desai and Amram Migdal
In 2022, AXA and its CEO Thomas Buberl faced new types of challenges, including systemic risks such as climate change, geopolitical instability, public health crises, and social tensions caused by economic risks. AXA was one of the world’s largest insurers. Since...
View Details
Keywords:
Change;
Change Management;
Transformation;
Transition;
Trends;
Environmental Management;
Climate Change;
Ethics;
Values and Beliefs;
Finance;
Insurance;
Management;
Management Succession;
Risk Management;
Organizations;
Corporate Social Responsibility and Impact;
Mission and Purpose;
Organizational Change and Adaptation;
Planning;
Strategic Planning;
Risk and Uncertainty;
Society;
Human Needs;
Social Issues;
Strategy;
Adaptation;
Business Strategy;
Corporate Strategy;
Insurance Industry;
Europe;
France;
Paris
Joly, Hubert, Mihir Desai, and Amram Migdal. "Thomas Buberl: Refounding AXA." Harvard Business School Case 523-059, January 2023.
- November 2007
- Case
Antegren: A Beacon of Hope
By: Joshua D. Margolis, Thomas J. DeLong and Terence Heymann
The CEO of Biogen Idec faces a set of difficult decisions regarding a promising drug for Multiple Sclerosis that is headed for early approval by the FDA. The first in a series focuses on operational decisions triggered by the drive for early approval. Sparks discussion...
View Details
Keywords:
Demand and Consumers;
Leadership;
Ethics;
Corporate Social Responsibility and Impact;
Decision Choices and Conditions;
Crisis Management;
Health Testing and Trials;
Biotechnology Industry;
Pharmaceutical Industry
Margolis, Joshua D., Thomas J. DeLong, and Terence Heymann. "Antegren: A Beacon of Hope." Harvard Business School Case 408-025, November 2007.
- 06 Sep 2022
- Research & Ideas
Curbing an Unlikely Culprit of Rising Drug Prices: Pharmaceutical Donations
Prescription drug costs continue to climb in the United States, but tightening a loophole in a federal law may help curb rising expenses, according to research published this week in Health Affairs. Efforts to control US View Details
- Web
Hiring Organizations
Employment Data Hiring Organizations Employment Data Hiring Organizations The below organizations hired an MBA graduate from the Class of 2023 or a summer intern from the Class of 2024. ABCDEFGHIJKLMNOPQRSTUVWXYZ# A A to Z Impact Aara View Details
- June 2010 (Revised September 2010)
- Case
athenahealth: Innovating in Response to a Crisis in Healthcare
When Jonathan Bush and his partner, Todd Park, realized that their revolutionary approach to delivering clinical care was being stymied by the inefficiencies in the healthcare system and insurance red tape, they turned their proprietary technology, athenaNet, to a new...
View Details
Keywords:
Entrepreneurship;
Health Care and Treatment;
Information Management;
Innovation and Invention;
Brands and Branding;
Product Development;
Health Industry;
United States
Chakravorti, Bhaskar, Laura Winig, and Naeem Husain Arastu. "athenahealth: Innovating in Response to a Crisis in Healthcare." Harvard Business School Case 810-079, June 2010. (Revised September 2010.)